Legal & General Group
PRAH

Legal & General Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Legal & General Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-108,338
Closed -$17.9M – 3541
2021
Q2 		$17.9M Sell
108,338
-33,412
-24% -$5.58M 0.01% 925
2021
Q1 		$21.7M Buy
141,750
+5,911
+4% +$803K 0.01% 854
2020
Q4 		$17M Sell
135,839
-6,296
-4% -$704K 0.01% 885
2020
Q3 		$14.4M Buy
142,135
+6,327
+5% +$645K 0.01% 879
2020
Q2 		$13.2M Buy
135,808
+5,790
+4% +$539K 0.01% 894
2020
Q1 		$10.8M Buy
130,018
+3,991
+3% +$389K 0.01% 878
2019
Q4 		$14M Sell
126,027
-4,069
-3% -$419K 0.01% 908
2019
Q3 		$12.9M Buy
130,096
+11,034
+9% +$1.1M 0.01% 901
2019
Q2 		$11.8M Buy
119,062
+52,616
+79% +$5.02M 0.01% 927
2019
Q1 		$7.33M Buy
66,446
+1,215
+2% +$127K ﹤0.01% 995
2018
Q4 		$6M Buy
65,231
+4,877
+8% +$493K ﹤0.01% 985
2018
Q3 		$6.65M Buy
60,354
+6,348
+12% +$661K ﹤0.01% 1024
2018
Q2 		$5.04M Buy
54,006
+33,647
+165% +$2.9M ﹤0.01% 1113
2018
Q1 		$1.69M Sell
20,359
-1,209
-6% -$107K ﹤0.01% 1695
2017
Q4 		$1.96M Buy
21,568
+1,654
+8% +$138K ﹤0.01% 1629
2017
Q3 		$1.51M Buy
19,914
+5,963
+43% +$451K ﹤0.01% 1700
2017
Q2 		$1.05M Buy
13,951
+4,008
+40% +$278K ﹤0.01% 1808
2017
Q1 		$649K Buy
9,943
+663
+7% +$39.1K ﹤0.01% 1946
2016
Q4 		$511K Buy
9,280
+2,803
+43% +$154K ﹤0.01% 1974
2016
Q3 		$361K Buy
6,477
+754
+13% +$37K ﹤0.01% 1853
2016
Q2 		$238K Buy
5,723
+820
+17% +$37.8K ﹤0.01% 1707
2016
Q1 		$211K Buy
4,903
+1,350
+38% +$57K ﹤0.01% 1723
2015
Q4 		$163K Buy
3,553
+700
+25% +$29.4K ﹤0.01% 1838
2015
Q3 		$109K Hold
2,853
– – ﹤0.01% 1988
2015
Q2 		$102K Buy
2,853
+407
+17% +$12.9K ﹤0.01% 2104
2015
Q1 		$71K Hold
2,446
– – ﹤0.01% 2282
2014
Q4 		$60K Buy
+2,446
New +$55.1K ﹤0.01% 2332

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Legal & General Group's PRAH Position: Q3 2021 in Review

Legal & General Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 108,338 shares — an estimated $17.9M sold.

Legal & General Group first reported a position in PRAH in Q4 2014 and held it in 27 quarters. The position peaked at $21.7M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Legal & General Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Legal & General Group sold 108,338 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $17.9M.
  • Legal & General Group first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 27 quarters.
  • Legal & General Group's PRA Health Sciences, Inc. position peaked at $21.7M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Legal & General Group's 13F filing for Q3 2021, filed 15 Nov 2021.